Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioCryst Pharmaceuticals Inc BCRX

Healthcare Biotechnology
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with complement-mediated and other rare diseases. The Company leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of... see more

Recent & Breaking News (NDAQ:BCRX)

BioCryst Reports First Quarter 2016 Financial Results

GlobeNewswire May 5, 2016

BioCryst to Announce First Quarter 2016 Financial Results May 5

GlobeNewswire April 21, 2016

BioCryst to Present at Two Upcoming Investor Conferences

GlobeNewswire April 7, 2016

BioCryst to Present at Barclays Healthcare Conference

GlobeNewswire March 9, 2016

Study Results From Zika Virus Infected Mice Treated With BCX4430 to be Presented at WHO Conference

GlobeNewswire March 7, 2016

BioCryst Reports Fourth Quarter & Full Year 2015 Financial Results

GlobeNewswire February 23, 2016

BioCryst to Announce Fourth Quarter & 2015 Financial Results February 23

Press Releases February 16, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Violations of Federal Securities Laws by the Board of BioCryst Pharmaceuticals, Inc. -- BCRX

Business Wire February 8, 2016

BioCryst Announces Results From OPuS-2

GlobeNewswire February 8, 2016

WHO Declares Zika A Health Emergency of International Concern: 5 Companies Developing Technologies in the Fight against the Epidemic

Accesswire February 3, 2016

BioCryst to Present at the J.P. Morgan Healthcare Conference

GlobeNewswire January 4, 2016

BioCryst To Present At Two Upcoming Investor Conferences

GlobeNewswire November 24, 2015

BioCryst Reports Third Quarter 2015 Financial Results

GlobeNewswire November 5, 2015

Biocryst to Present at the Jefferies Autumn 2015 Global Healthcare Conference

GlobeNewswire November 4, 2015

BioCryst to Announce Third Quarter 2015 Financial Results November 5

GlobeNewswire October 27, 2015

BioCryst Announces Completion of Patient Enrollment in OPuS-2: a Clinical Trial of Avoralstat in Patients With HAE

GlobeNewswire October 8, 2015

BioCryst Announces Successful Phase 1 Clinical Trial of BCX7353

GlobeNewswire October 8, 2015

Sanj K. Patel Appointed to BioCryst's Board of Directors

GlobeNewswire September 29, 2015

BioCryst Reports Second Quarter 2015 Financial Results

GlobeNewswire August 7, 2015

BioCryst Reports Second Quarter 2015 Financial Results

GlobeNewswire August 7, 2015